1 to be safe and effective in the treatment of neoplastic meningitis.

2 followed by a phase I trial in patients with neoplastic meningitis.

3 c effects in patients 3 years and older with neoplastic meningitis.

4 methotrexate (MTX) as the sole treatment for neoplastic meningitis.

5 sing entities of 'meningeal carcinomatosis', neoplastic meningitis' and 'leukaemic/lymphomatous menin

6                      Standard treatments for neoplastic meningitis are only modestly effective and ar

7 e use of i.t. chemotherapy for patients with neoplastic meningitis are warranted.

8 ecognition of the clinical manifestations of neoplastic meningitis followed by neuroradiography of th

9 erapy for ovarian ascites tumors in mice and neoplastic meningitis in rats.

10                                              Neoplastic meningitis is a disease of the entire neuraxi

11 se II trial of IT topotecan in children with neoplastic meningitis is in progress.

12                                              Neoplastic meningitis (NM) is a common problem in neuro-

13      In the 15 patients with inflammatory or neoplastic meningitis only (six patients with acute suba